Cas:7570-37-8 4-[(E)-2-(4-Methoxyphenyl)vinyl]aniline manufacturer & supplier

Chemical Name:4-[(E)-2-(4-Methoxyphenyl)vinyl]aniline

CAS.NO:7570-37-8

Synonyms:4′-Methoxy-stilben-4-ylamin;Aminomethoxystilbene;4-[(E)-2-(4-Methoxyphenyl)vinyl]aniline;4-[(E)-2-(4-Methoxyphenyl)ethenyl]phenylamine;p-methoxy-p’-aminostilbene;Benzenamine, 4-[(E)-2-(4-methoxyphenyl)ethenyl]-;4-Amino-4′-methoxistilben;4′-METHOXY-4-STILBENAMINE;4′-methoxy-stilben-4-ylamine;4′-Amino-4-methoxy-stilben

Molecular Formula:C₁₅H₁₅NO

Molecular Weight:225.286

HS Code:2922199090

Physical and Chemical Properties:

Melting point:173ºC

Boiling point:412.4±24.0 °C at 760 mmHg

Density:1.1±0.1 g/cm3

Index of Refraction:1.673

PSA:35.25000

Exact Mass:225.115356

LogP:3.50

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4′-Methoxy-stilben-4-ylamin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4′-Amino-4-methoxy-stilben physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,p-methoxy-p’-aminostilbene Use and application,4-Amino-4′-methoxistilben technical grade,usp/ep/jp grade.

Related News: In a memo to Branchburg employees on May 20, Nellie Clark, head of the plant, summed up the outside lawyers’ findings: “In the end and very importantly, allegations that Lilly made false statements to the FDA were not substantiated.” 4-[(E)-2-(4-Methoxyphenyl)vinyl]aniline manufacturer No amount of unmet need can take the place of sufficient evidence, said Johns Hopkins public health professor Dr. Caleb Alexander, a member of the FDA advisory panel. 4-[(E)-2-(4-Methoxyphenyl)vinyl]aniline supplier In a memo to Branchburg employees on May 20, Nellie Clark, head of the plant, summed up the outside lawyers’ findings: “In the end and very importantly, allegations that Lilly made false statements to the FDA were not substantiated.” 4-[(E)-2-(4-Methoxyphenyl)vinyl]aniline vendor No amount of unmet need can take the place of sufficient evidence, said Johns Hopkins public health professor Dr. Caleb Alexander, a member of the FDA advisory panel. 4-[(E)-2-(4-Methoxyphenyl)vinyl]aniline factory It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion.